首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Reviews in endocrine & metabolic disorders

缩写:REV ENDOCR METAB DIS

ISSN:1389-9155

e-ISSN:1573-2606

IF/分区:8.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引867
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jan Hansen,Birgitte Brock,Hans Erik Bøtker et al. Jan Hansen et al.
The gut hormone glucagon-like peptide-1 (GLP-1) is an insulinotropic incretin with significant cardiovascular impact. Two classes of medication, GLP-1 analogues and DPP-4 inhibitors, have been developed that circumvent the rapid degradation...
Adam G Goodwill,Kieren J Mather,Abass M Conteh et al. Adam G Goodwill et al.
Glucagon-like peptide-1 (GLP-1) is an incretin hormone that has been shown to have hemodynamic and cardioprotective capacity in addition to its better characterized glucoregulatory actions. Because of this, emerging research has focused on ...
Meera Shah,Adrian Vella Meera Shah
Glucagon-like peptide 1 (GLP-1) is a cleavage product of the pre-proglucagon gene which is expressed in the α-cells of the pancreas, the L-cells of the intestine, and neurons located in the caudal brainstem and hypothalamus. GLP-1 is of re...
Jeppe Skov Jeppe Skov
The incretin hormone, glucagon-like peptide-1 (GLP-1), stimulates insulin secretion and forms the basis of a new drug class for diabetes treatment. GLP-1 has several extra-pancreatic properties which include effects on kidney function. Alth...
Amandine Everard,Patrice D Cani Amandine Everard
A large body of evidence suggests that the regulation of energy balance and glucose homeostasis by fermentable carbohydrates induces specific changes in the gut microbiota. Among the mechanisms, our research group and others have demonstrat...
Vladimer Darsalia,David Nathanson,Thomas Nyström et al. Vladimer Darsalia et al.
Stroke is the leading cause of adult disability in Westernized societies with increased incidence along ageing and it represents a major health and economical threat. Inactive lifestyle, smoking, hypertension, atherosclerosis, obesity and d...
Terry P Combs,Errol B Marliss Terry P Combs
High glucose production contributes to fed and fasted hyperglycemia in Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D). The breakdown of the adiponectin signaling pathway in T1D and the reduction of circulating adiponectin in T2D contribute...
Elaine Xu,Michael Schwab,André Marette Elaine Xu
Insulin resistance is a major disorder that links obesity to type 2 diabetes mellitus (T2D). It involves defects in the insulin actions owing to a reduced ability of insulin to trigger key signaling pathways in major metabolic tissues. The ...
Nam Ho Jeoung,Chris R Harris,Robert A Harris Nam Ho Jeoung
Pyruvate is an obligatory intermediate in the oxidative disposal of glucose and a major precursor for the synthesis of glucose, glycerol, fatty acids, and non-essential amino acids. Stringent control of the fate of pyruvate is critically im...
Maria Paula Macedo,Inês S Lima,Joana M Gaspar et al. Maria Paula Macedo et al.
Ingestion of a meal is the greatest challenge faced by glucose homeostasis. The surge of nutrients has to be disposed quickly, as high concentrations in the bloodstream may have pathophysiological effects, and also properly, as misplaced re...